< Back to previous page

Publication

A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study (vol 21, 1005, 2020)

Journal Contribution - Journal Article

Journal: Trials

ISSN: 1745-6215

Issue: 1

Volume: 21

Publication year:2020

WoS Id: 000605609400002
PubMed Id: 33375932
DOI: https://doi.org/10.1186/s13063-020-04991-y
Institutional Repository URL: https://lirias.kuleuven.be/3355329

See also: Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study